Medifacts International, Inc.
Young Conaway acted as lead counsel to Medifacts International, Inc. in its chapter 11 proceeding in the United States Bankruptcy Court for the District of Delaware. The Debtor was in the business of providing clinical trial services to pharmaceutical, biotech and medical device companies that are developing therapeutic drugs and products. The Debtor was also a global leader in cardiac safety monitoring services, including ambulatory blood pressure monitoring, ECG and Holder. With Young Conaway’s assistance, the Debtor successfully confirmed its chapter 11 plan of reorganization and emerged from bankruptcy in 2007.